33879-72-0

Basic information

• Product Name: 1,3-Pentanediol, 3-methyl-
• Synonyms: 1,3-Pentanediol,3-methyl;3-Methyl-pentan-1,3-diol;3-Methylpenten-1,3-diol;3-methyl-pentane-1,3-diol;3-methyl-1,3-pentanediol
• CAS NO: 33879-72-0
• Molecular Formula: C6H14O2
• Molecular Weight: 118.176
• Mol File: 33879-72-0.mol
• Article Data: 4

Chemical Properties

• Melting Point: 26.38°C (estimate)
• Boiling Point: 221.7°C (rough estimate)
• Density: 0.9843 (rough estimate)
• Refractive Index: 1.4420 (estimate)
• CAS DataBase Reference: 1,3-Pentanediol, 3-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Pentanediol, 3-methyl-(33879-72-0)
• EPA Substance Registry System: 1,3-Pentanediol, 3-methyl-(33879-72-0)

Safety Data

• Hazardous Substances Data: 33879-72-0(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 3647-33-4 3-ethyl-3-methyl-oxiranecarboxylic acid ethyl ester 
• 31033-23-5 ethyl 3-hydroxy-3-methylpentenoate 
• 945684-65-1 (S)-(-)-3-(dimethylphenylsilyl)-3-methyl-1-pentanol 
• 77-75-8 meparfynol 
• 33879-63-9 2-methyl-2-vinyl-oxetane 
• 590-90-9 1-Hydroxy-3-butanone 
• 59954-67-5 3,4-epoxy-3-methylbutanol 
• 102276-92-6 methylmagnesium N-cyclohexylisopropylamide 
• 20941-07-5 3-methyl-3-hydroxy-4-pentenyl-1-ol 
• 23206-28-2 2-ethyl-2-methyloxetane 
• 150-96-9 3-hydroxy-3-methylpentanoic acid 
• 918-85-4 3-hydroxy-3-methyl-1-pentene 

Relevant articles and documents

BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6

The present invention relates to compounds of Formula I that function as inhibitors of BCL6 (B-cell lymphoma 6) activity: wherein X1, X2, R1, R2 and R3 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which BCL6 activity is implicated.

Mutation and inhibition studies of mevalonate 5-diphosphate decarboxylase

Mevalonate 5-diphosphate decarboxylase plays an important role in regulating cholesterol biosynthesis, which was studied through incubation with various synthetic substrate analogs and characterization of mutated enzymes. The results are potentially useful for further developing inhibitors that block the mevalonate pathway which is a drug target for treating cardiovascular disease and cancer.